These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 23028685)

  • 1. The anti-cancer IgM monoclonal antibody PAT-SM6 binds with high avidity to the unfolded protein response regulator GRP78.
    Rosenes Z; Mulhern TD; Hatters DM; Ilag LL; Power BE; Hosking C; Hensel F; Howlett GJ; Mok YF
    PLoS One; 2012; 7(9):e44927. PubMed ID: 23028685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous binding of the anti-cancer IgM monoclonal antibody PAT-SM6 to low density lipoproteins and GRP78.
    Rosenes Z; Mok YF; Yang S; Griffin MD; Mulhern TD; Hatters DM; Hensel F; Howlett GJ
    PLoS One; 2013; 8(4):e61239. PubMed ID: 23620733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early development of PAT-SM6 for the treatment of melanoma.
    Hensel F; Eckstein M; Rosenwald A; Brändlein S
    Melanoma Res; 2013 Aug; 23(4):264-75. PubMed ID: 23728394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The natural human IgM antibody PAT-SM6 induces apoptosis in primary human multiple myeloma cells by targeting heat shock protein GRP78.
    Rasche L; Duell J; Morgner C; Chatterjee M; Hensel F; Rosenwald A; Einsele H; Topp MS; Brändlein S
    PLoS One; 2013; 8(5):e63414. PubMed ID: 23667612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A GRP78-Directed Monoclonal Antibody Recaptures Response in Refractory Multiple Myeloma with Extramedullary Involvement.
    Rasche L; Menoret E; Dubljevic V; Menu E; Vanderkerken K; Lapa C; Steinbrunn T; Chatterjee M; Knop S; Düll J; Greenwood DL; Hensel F; Rosenwald A; Einsele H; Brändlein S
    Clin Cancer Res; 2016 Sep; 22(17):4341-9. PubMed ID: 27029491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GRP78-directed immunotherapy in relapsed or refractory multiple myeloma - results from a phase 1 trial with the monoclonal immunoglobulin M antibody PAT-SM6.
    Rasche L; Duell J; Castro IC; Dubljevic V; Chatterjee M; Knop S; Hensel F; Rosenwald A; Einsele H; Topp MS; Brändlein S
    Haematologica; 2015 Mar; 100(3):377-84. PubMed ID: 25637055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new tumor-specific variant of GRP78 as target for antibody-based therapy.
    Rauschert N; Brändlein S; Holzinger E; Hensel F; Müller-Hermelink HK; Vollmers HP
    Lab Invest; 2008 Apr; 88(4):375-86. PubMed ID: 18268478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A murine monoclonal antibody directed against the carboxyl-terminal domain of GRP78 suppresses melanoma growth in mice.
    de Ridder GG; Ray R; Pizzo SV
    Melanoma Res; 2012 Jun; 22(3):225-35. PubMed ID: 22495669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phage display derived human monoclonal antibodies isolated by binding to the surface of live primary breast cancer cells recognize GRP78.
    Jakobsen CG; Rasmussen N; Laenkholm AV; Ditzel HJ
    Cancer Res; 2007 Oct; 67(19):9507-17. PubMed ID: 17909061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of anti-GRP78 autoantibodies to cell surface GRP78 increases tissue factor procoagulant activity via the release of calcium from endoplasmic reticulum stores.
    Al-Hashimi AA; Caldwell J; Gonzalez-Gronow M; Pizzo SV; Aboumrad D; Pozza L; Al-Bayati H; Weitz JI; Stafford A; Chan H; Kapoor A; Jacobsen DW; Dickhout JG; Austin RC
    J Biol Chem; 2010 Sep; 285(37):28912-23. PubMed ID: 20605795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. La3+ binds to BiP/GRP78 and induces unfolded protein response in HepG2 cells.
    Shen C; Li Z; Yang X; Wang K
    Chem Biol Interact; 2008 Nov; 176(2-3):196-203. PubMed ID: 18773883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell Surface GRP78 as a Death Receptor and an Anticancer Drug Target.
    Ge R; Kao C
    Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31766302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies against the cell surface-associated chaperone GRP78 stimulate tumor growth via tissue factor.
    Al-Hashimi AA; Lebeau P; Majeed F; Polena E; Lhotak Š; Collins CAF; Pinthus JH; Gonzalez-Gronow M; Hoogenes J; Pizzo SV; Crowther M; Kapoor A; Rak J; Gyulay G; D'Angelo S; Marchiò S; Pasqualini R; Arap W; Shayegan B; Austin RC
    J Biol Chem; 2017 Dec; 292(51):21180-21192. PubMed ID: 29066620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GRP78 targeting: Hitting two birds with a stone.
    Elfiky AA; Baghdady AM; Ali SA; Ahmed MI
    Life Sci; 2020 Nov; 260():118317. PubMed ID: 32841659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Avidity distribution of antibodies against peripheral nerve myelin in patients with polyneuropathy associated with IgM monoclonal gammopathy and in healthy controls.
    Vrethem M; Ekerfelt C; Ernerudh J
    J Neurol Sci; 1995 Aug; 131(2):190-9. PubMed ID: 7595646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CLPTM1L/CRR9 ectodomain interaction with GRP78 at the cell surface signals for survival and chemoresistance upon ER stress in pancreatic adenocarcinoma cells.
    Clarke WR; Amundadottir L; James MA
    Int J Cancer; 2019 Mar; 144(6):1367-1378. PubMed ID: 30468251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of GRP78, Master Regulator of the Unfolded Protein Response, Increases Chemoresistance in Pancreatic Ductal Adenocarcinoma.
    Gifford JB; Huang W; Zeleniak AE; Hindoyan A; Wu H; Donahue TR; Hill R
    Mol Cancer Ther; 2016 May; 15(5):1043-52. PubMed ID: 26939701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and glycoengineering of functionally active heteromultimeric IgM in plants.
    Loos A; Gruber C; Altmann F; Mehofer U; Hensel F; Grandits M; Oostenbrink C; Stadlmayr G; Furtmüller PG; Steinkellner H
    Proc Natl Acad Sci U S A; 2014 Apr; 111(17):6263-8. PubMed ID: 24706782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A high throughput substrate binding assay reveals hexachlorophene as an inhibitor of the ER-resident HSP70 chaperone GRP78.
    Ambrose AJ; Zerio CJ; Sivinski J; Schmidlin CJ; Shi T; Ross AB; Widrick KJ; Johnson SM; Zhang DD; Chapman E
    Bioorg Med Chem Lett; 2019 Jul; 29(14):1689-1693. PubMed ID: 31129054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer cell proliferation in vitro is modulated by antibodies against glucose-regulated protein 78 isolated from patient serum.
    Gonzalez-Gronow M; Cuchacovich M; Llanos C; Urzua C; Gawdi G; Pizzo SV
    Cancer Res; 2006 Dec; 66(23):11424-31. PubMed ID: 17145889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.